Eli Lilly and Company (NYSE: LLY) is a pharmaceutical company that discovers, develops, manufactures, and sells prescription medicines. Revenue is generated through transactional sales of branded drugs to wholesalers, pharmacies, hospitals, and government payers, with pricing set at the brand level and subject to rebates and formulary negotiations. The filing excerpts provided do not contain sufficient detail to characterize segment revenue percentages, key product names, competitive position, geographic mix, leadership tenure, or founding history. Accordingly, those specifics are omitted. What the cover page of the 10-K filed February 12, 2026 (accession 0000059478-26-000013) confirms is that Lilly is a well-known seasoned issuer registered under Section 12(b) of the Securities Exchange Act, with securities listed on a national exchange under the ticker LLY, and that it files annual reports for fiscal years ended in accordance with SEC requirements.

Revenue model

Transactional sales of branded prescription medicines to wholesalers, pharmacies, hospitals, and government payers, with net revenue reduced by rebates and payer negotiations. Specific revenue figures are not supported by the provided filing excerpts.

Products and services

Prescription pharmaceutical products. Specific drug names, therapeutic categories, and brand portfolios are not supported by the provided filing excerpts.

Customers and end markets

Wholesalers, pharmacies, hospitals, and government payers in prescription pharmaceutical end markets. Specific customer concentration data are not supported by the provided filing excerpts.

Value-chain role

Integrated pharmaceutical manufacturer: drug discovery, clinical development, manufacturing, and commercial sales of branded prescription medicines.

Geographic exposure

Not supported by the provided filing excerpts.

Source: SEC 10-K, filed 2026-02-12

Industry: Pharmaceutical Preparations Peers: Bristol-Myers Squibb Co Catalent, Inc. Johnson & Johnson Merck & Co Inc Organon & Co Pfizer Inc Royalty Pharma PLC Viatris Inc Zoetis Inc